101 related articles for article (PubMed ID: 73485)
21. Reverse transcription of the viral genome associated with the plasma membrane after infection with RNA tumor viruses.
Kakefuda T; Dingman CW; Bak TM; Hatanaka M; Kitano Y
Cancer Res; 1974 Apr; 34(4):679-88. PubMed ID: 4131154
[No Abstract] [Full Text] [Related]
22. Karyology: vaccine manufacturers' views.
von Seefried A; Walton MJ; MacMorine HG
Dev Biol Stand; 1976 Dec 13-15; 37():169-75. PubMed ID: 801470
[TBL] [Abstract][Full Text] [Related]
23. Suspension-Vero cell cultures as a platform for viral vaccine production.
Paillet C; Forno G; Kratje R; Etcheverrigaray M
Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
[TBL] [Abstract][Full Text] [Related]
24. Use of cell cultures in vaccine production: diploid and stable cell cultures.
Matchett A
J Am Vet Med Assoc; 1970 Jun; 156(12):1791-4. PubMed ID: 4987214
[No Abstract] [Full Text] [Related]
25. The need for non-cultural methods for the detection of mycoplasma contaminants.
Stanbridge EJ; Schneider EL
Dev Biol Stand; 1976 Dec 13-15; 37():191-200. PubMed ID: 1031685
[TBL] [Abstract][Full Text] [Related]
26. Relatedness of RNA and reverse transcriptase from human acute myelogenous leukemia cells and from RNA tumor viruses.
Gallagher RE; Mondal H; Miller DP; Todaro GJ; Gillespie DH; Gallo RC
Hamatol Bluttransfus; 1974; 14():185-96. PubMed ID: 4141321
[No Abstract] [Full Text] [Related]
27. Suggested methods for the management and testing of a passaged diploid cell culture used for virus vaccine production.
Perkins FT
Jpn J Med Sci Biol; 1971 Oct; 24(5):342-4. PubMed ID: 5316784
[No Abstract] [Full Text] [Related]
28. Quantification of endogenous viral polymerase, 3D(pol), in preparations of Mengo and encephalomyocarditis viruses.
Frolov VG; Duque H; Palmenberg AC
Virology; 1999 Jul; 260(1):148-55. PubMed ID: 10405366
[TBL] [Abstract][Full Text] [Related]
29. The choice of the cell substrate for human virus vaccine production.
Hayflick L
Lab Pract; 1970 Jan; 19(1):58-62. PubMed ID: 4984599
[No Abstract] [Full Text] [Related]
30. Production of human virus vaccines in primary mammalian cells.
Stones PB
Lab Pract; 1970 Jan; 19(1):40-1 passim. PubMed ID: 4984598
[No Abstract] [Full Text] [Related]
31. Search for endogenous C-type viruses in cultures of non leukemic human cells.
Bernard C; Chuat JC; Olivie M
Biomedicine; 1978 Jun; 29(4):143-6. PubMed ID: 80236
[TBL] [Abstract][Full Text] [Related]
32. Mammalian cells and their contaminants.
Minor PD
Dev Biol Stand; 1996; 88():25-9. PubMed ID: 9119147
[No Abstract] [Full Text] [Related]
33. [Cell-containing substrates and vaccine production].
Majer M
Schweiz Med Wochenschr; 1970 Nov; 100(48):2086-9. PubMed ID: 5003834
[No Abstract] [Full Text] [Related]
34. Origin of endogenous and exogenous agents in cell cultures.
Hopps HE
In Vitro; 1974; 10(5-6):243-6. PubMed ID: 4217763
[No Abstract] [Full Text] [Related]
35. An efficient helper-virus-free method for rescue of recombinant paramyxoviruses and rhadoviruses from a cell line suitable for vaccine development.
Witko SE; Kotash CS; Nowak RM; Johnson JE; Boutilier LA; Melville KJ; Heron SG; Clarke DK; Abramovitz AS; Hendry RM; Sidhu MS; Udem SA; Parks CL
J Virol Methods; 2006 Jul; 135(1):91-101. PubMed ID: 16569439
[TBL] [Abstract][Full Text] [Related]
36. Nonhuman primate diploid cells for vaccine production.
Petricciani JC
Dev Biol Stand; 1976 Dec 13-15; 37():21-5. PubMed ID: 1036399
[TBL] [Abstract][Full Text] [Related]
37. Operator-induced contamination in cell culture systems.
Hay RJ
Dev Biol Stand; 1991; 75():193-204. PubMed ID: 1794620
[TBL] [Abstract][Full Text] [Related]
38. Search for retrovirus-like particles in human breast cancer cells in culture.
Strauchen JA; Arya SK; Tralka TS; Engel LW; Young NA
Cancer Res; 1980 Nov; 40(11):3880-5. PubMed ID: 6162539
[TBL] [Abstract][Full Text] [Related]
39. In vitro HIV infection of primate lymphocytes.
Kraiselburd EN; Williams DC; Kessler MJ
P R Health Sci J; 1990 Aug; 9(2):161-4. PubMed ID: 1706529
[TBL] [Abstract][Full Text] [Related]
40. New trends in the preparation of cell substrates for the production of virus vaccines.
van Wezel AL
Prog Immunobiol Stand; 1971; 5():187-92. PubMed ID: 4349819
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
